Pancreatic cancer epidemiology and demographics


 * Associate Editor-In-Chief:

Overview
Pancreatic cancer is a malignant tumour within the pancreatic gland. Each year about 33,000 individuals in the United States are diagnosed with this condition, and more than 60,000 in Europe. Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor, with few victims still alive five years after diagnosis, and complete remission still extremely rare.

About 95 percent of pancreatic tumors are adenocarcinomas. The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic neuroendocrine tumors (such as insulinomas,, ). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.

Awareness

 * November is Pancreatic Cancer Awareness ribbon|Awareness Month
 * Purple is the traditional color chosen to represent pancreatic cancer awareness.
 * The National Cancer Institute’s cancer research budget was $4.824 billion in 2004, an estimated $52.7 million of which was devoted to pancreatic cancer.
 * Research spending per pancreatic cancer patient is $1145, the lowest of any leading cancer.
 * For a list of celebrities who have succumbed to this disease, see
 * The Pancreatic Cancer Action Network (PanCAN) was created as an advocacy group for pancreatic cancer.
 * The national charity Pancreatic Cancer UK works to raise awareness in the UK